Various genetic studies, from classical single nucleotide polymorphism to genome-wide association studies, consistently demonstrate associations of the dopamine receptor D2 (DRD2) gene with leading pathophysiological hypotheses of schizophrenia [Schizophrenia Working Group]. Here, DRD2 is linked to schizophrenia.